Mar. 27, 2026
Shield AI Raises $1.5 Billion at $12.7 Billion Valuation Amid Global Conflicts
The defense tech company secures non-dilutive financing to accelerate its autonomous warfare platform amid rising geopolitical tensions.
Mar. 17, 2026
VST BIO Corporation Raises $45M in Series A Financing
Funds will advance lead stroke therapy VB-001 into first-in-human trials and expand platform.
Mar. 12, 2026
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
The company is exploring potential partnerships, mergers, or acquisitions with the help of an investment bank.
Mar. 12, 2026
AnaptysBio Outlines Plans for Spin-Off and Jemperli Royalty Surge
Biopharma company details timeline for separating into royalty and operating entities
Mar. 11, 2026
AnaptysBio Plans First Tracks Spin-Off as Jemperli Royalties Surge, Buybacks Possible
The company expects to create a new entity, First Tracks Biotherapeutics, within the next few months.
Mar. 3, 2026
From a Mobile Truck to 51 Locations and Counting: The Unstoppable Rise of goGLOW
How a former Probation Officer turned a side hustle into one of the fastest-growing beauty franchises in the country
